Propranolol as first-line treatment of head and neck hemangiomas

Archives of Otolaryngology - Head and Neck Surgery

Volumn 137, Issue 5, 2011, Pages 471-478

  Fuchsmann, Carine ^a,b   Quintal, Marie Claude ^c   Giguere, Chantal ^c   Ayari Khalfallah, Sonia ^a   Guibaud, Laurent ^a   Powell, Julie ^c   McCone, Catherine ^c   Froehlich, Patrick ^a,b,c  

^a HOSPICES CIVILS DE LYON   (France)

^b UNIVERSITÉ LYON 1   (France)

^c UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; BETAMETHASONE; CORTICOSTEROID; GLUCOSE; PREDNISONE; PROPRANOLOL;

AROUSAL; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; CUSHING SYNDROME; DIARRHEA; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; DYSPNEA; FEMALE; GLUCOSE BLOOD LEVEL; GROWTH DISORDER; HEAD AND NECK INFANTILE HEMANGIOMA; HEAD AND NECK TUMOR; HEART DISEASE; HEMANGIOMA; HUMAN; HYPOGLYCEMIA; INFANT; INFANT DISEASE; LOW LEVEL LASER THERAPY; MALE; MEDICAL RECORD REVIEW; NIGHTMARE; SIDE EFFECT; SLEEP DISORDER; TERTIARY HEALTH CARE; THERAPY DELAY; TREATMENT DURATION; TUMOR LOCALIZATION; TUMOR RECURRENCE; TUMOR REGRESSION;

EID: 79956104537     PISSN: 08864470     EISSN: 1538361X     Source Type: Journal    
DOI: 10.1001/archoto.2011.55     Document Type: Article

References (20)

1. Frieden IJ, Haggstrom AN, Drolet BA, et al. Infantile hemangiomas: current knowledge, future directions: proceedings of a research workshop on infantile hemangiomas, April 7-9, 2005, Bethesda, Maryland, USA. Pediatr Dermatol. 2005;22(5):383-406. (Pubitemid 43960991)
2. Margileth AM, Museles M. Cutaneous hemangiomas in children: diagnosis and conservative management. JAMA. 1965;194(5):523-526.
3. Bennett ML, Fleischer AB Jr, Chamlin SL, Frieden IJ. Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation. Arch Dermatol. 2001;137(9):1208-1213. (Pubitemid 32847844)
4. George ME, Sharma V, Jacobson J, Simon S, Nopper AJ. Adverse effects of systemic glucocorticosteroid therapy in infants with hemangiomas. Arch Dermatol. 2004;140(8):963-969. (Pubitemid 39062647)
5. Ezekowitz RA, Mulliken JB, Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy [published corrections appear in N Engl J Med. 1995;333(9):595-596 and 1994;330(4):300]. N Engl J Med. 1992;326(22):1456-1463.
6. Enjolras O, Brevière GM, Roger G, et al. Vincristine treatment for function- and life-threatening infantile hemangioma. Arch Pediatr. 2004;11(2):99-107. (Pubitemid 38220704)
7. Michaud AP, Bauman NM, Burke DK, Manaligod JM, Smith RJ. Spastic diplegia and other motor disturbances in infants receiving interferon-alpha. Laryngoscope. 2004;114(7):1231-1236. (Pubitemid 38954577)
8. Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taïeb A. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358(24):2649-2651. (Pubitemid 351831393)
9. Denoyelle F, Leboulanger N, Enjolras O, Harris R, Roger G, Garabédian EN. Role of propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma. Int J Pediatr Otorhinolaryngol. 2009;73(8):1168-1172.
10. Truong MT, Chang KW, Berk DR, Heerema-McKenney A, Bruckner AL. Propranolol for the treatment of a life-threatening subglottic and mediastinal infantile hemangioma. J Pediatr. 2010;156(2):335-338.
11. Michel JL, Patural H. Response to oral propranolol therapy for ulcerated hemangiomas in infancy. Arch Pediatr. 2009;16(12):1565-1568.
12. Sans V, de la Roque ED, Berge J, et al. Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics. 2009;124(3):e423-e431. http://pediatrics .aappublications.org/cgi/content/full/124/3/e423. Accessed March 8, 2011.
13. Bigorre M, Van Kien AK, Valette H. β-Blocking agent for treatment of infantile hemangioma. Plast Reconstr Surg. 2009;123(6):195e-196e.
14. Perkins JA, Oliaei S, Garrison MM, Manning SC, Christakis DA. Airway procedures and hemangiomas: treatment patterns and outcome in U.S. pediatric hospitals. Int J Pediatr Otorhinolaryngol. 2009;73(9):1302-1307.
15. Perkins JA, Duke W, Chen E, Manning S. Emerging concepts in airway infantile hemangioma assessment and management. Otolaryngol Head Neck Surg. 2009;141(2):207-212.
16. Cotton RT, Tewfik TL. Laryngeal stenosis following carbon dioxide laser in subglottic hemangioma: report of three cases. Ann Otol Rhinol Laryngol. 1985;94(5, pt 1):494-497. (Pubitemid 16251272)
17. Maturo S, Hartnick C. Initial experience using propranolol as the sole treatment for infantile airway hemangiomas. Int J Pediatr Otorhinolaryngol. 2010;74(3):323-325.
18. Zimmermann AP, Wiegand S, Werner JA, Eivazi B. Propranolol therapy for infantile haemangiomas: review of the literature. Int J Pediatr Otorhinolaryngol. 2010;74(4):338-342.
19. Lawley LP, Siegfried E, Todd JL. Propranolol treatment for hemangioma of infancy: risks and recommendations. Pediatr Dermatol. 2009;26(5):610-614.
20. Léauté-Labrèze C, Taïeb A. Efficacy of β-blockers in infantile capillary haemangiomas: the physiopathological significance and therapeutic consequences. Ann Dermatol Venereol. 2008;135(12):860-862.